Alder Biopharmaceuticals
A biopharmaceutical company developing treatments for migraine and other neurological and inflammatory conditions
7
Funding Rounds
$540.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ra***** Sc******* | - | - | |
| Ma** Li**** | - | - | |
| Jo** La**** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Alder Biopharmaceuticals has raised a total of $53m in funding over 7 rounds.
Key Insights:
- Alder Biopharmaceuticals Series D round: $38m
- Alder Biopharmaceuticals funding round, June 2011: $15m
- Alder Biopharmaceuticals Venture round, January 2018: $250m
- Alder Biopharmaceuticals Series A round, July 2005: $11m
- Alder Biopharmaceuticals Series C round, December 2007: $40m
- Alder Biopharmaceuticals Series B round, July 2006: $16m
- Alder Biopharmaceuticals Venture round, April 2019: $170m
Alder Biopharmaceuticals Series D round
$38m
Alder Biopharmaceuticals funding round, June 2011
$15m
Alder Biopharmaceuticals Venture round, January 2018
$250m
Alder Biopharmaceuticals Series A round, July 2005
$11m
Alder Biopharmaceuticals Series C round, December 2007
$40m
Alder Biopharmaceuticals Series B round, July 2006
$16m
Alder Biopharmaceuticals Venture round, April 2019
$170m
Industries
Alder Biopharmaceuticals is active in the following industries:
- Biotechnology
- Therapeutics
- Healthcare
- Biology
- Consumer biotechnology
- Pharmaceutical industry
- Technology